Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
European Heart Journal
|
April 9, 2026
GLP-1 receptor agonists and atherosclerosis: a metabolic treatment for a cardiometabolic disease
Georgios Georgiopoulos, Simon Kraler, Kimon Stamatelopoulos
European Heart Journal
|
February 21, 2022
Calcific aortic valve disease: novel insights into nitric oxide signalling
Simon Kraler, Vidu Garg, Alexander Akhmedov
European Journal of Preventive Cardiology
|
January 19, 2026
Inflammation as a missing dimension in early risk stratification after myocardial infarction
Simon Kraler, Yifan Wang, Luca Liberale
European Heart Journal
|
December 2, 2025
From bile to vessels: linking obesity to endothelial dysfunction
Simon Kraler, Gemma Vilahur, Petra Kleinbongard
American Journal of Physiology. Heart and Circulatory Physiology
|
July 7, 2026
Coronary microvascular dysfunction: From diagnosis to therapy
Yifan Wang, Thomas F Lüscher, Simon Kraler
Trends in Cardiovascular Medicine
|
April 22, 2026
Cardiogenic Shock: Beyond Pump Failure
Aldo Bonaventura, Simon Kraler, Luca Liberale, et al.
European Journal of Clinical Investigation
|
October 22, 2020
Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial
Simon Kraler, Florian A Wenzl, Thomas F Lüscher
European Heart Journal
|
May 13, 2025
Acute coronary syndromes: mechanisms, challenges, and new opportunities
Simon Kraler, Christian Mueller, Peter Libby, et al.
Basic & Clinical Pharmacology & Toxicology
|
May 2, 2020
Ageing and longevity genes in cardiovascular diseases
Luca Liberale, Simon Kraler, Giovanni G Camici, et al.
Circulation Research
|
April 29, 2021
Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis
Mark C Blaser, Simon Kraler, Thomas F Lüscher, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
European Heart Journal
|
April 9, 2026
GLP-1 receptor agonists and atherosclerosis: a metabolic treatment for a cardiometabolic disease
Georgios Georgiopoulos, Simon Kraler, Kimon Stamatelopoulos
European Heart Journal
|
February 21, 2022
Calcific aortic valve disease: novel insights into nitric oxide signalling
Simon Kraler, Vidu Garg, Alexander Akhmedov
European Journal of Preventive Cardiology
|
January 19, 2026
Inflammation as a missing dimension in early risk stratification after myocardial infarction
Simon Kraler, Yifan Wang, Luca Liberale
European Heart Journal
|
December 2, 2025
From bile to vessels: linking obesity to endothelial dysfunction
Simon Kraler, Gemma Vilahur, Petra Kleinbongard
American Journal of Physiology. Heart and Circulatory Physiology
|
July 7, 2026
Coronary microvascular dysfunction: From diagnosis to therapy
Yifan Wang, Thomas F Lüscher, Simon Kraler
Trends in Cardiovascular Medicine
|
April 22, 2026
Cardiogenic Shock: Beyond Pump Failure
Aldo Bonaventura, Simon Kraler, Luca Liberale, et al.
European Journal of Clinical Investigation
|
October 22, 2020
Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial
Simon Kraler, Florian A Wenzl, Thomas F Lüscher
European Heart Journal
|
May 13, 2025
Acute coronary syndromes: mechanisms, challenges, and new opportunities
Simon Kraler, Christian Mueller, Peter Libby, et al.
Basic & Clinical Pharmacology & Toxicology
|
May 2, 2020
Ageing and longevity genes in cardiovascular diseases
Luca Liberale, Simon Kraler, Giovanni G Camici, et al.
Circulation Research
|
April 29, 2021
Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis
Mark C Blaser, Simon Kraler, Thomas F Lüscher, et al.
Page
of 6